Grantham, Mayo, Van Otterloo & Co (GMO)
JNJ icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Johnson & Johnson JNJ Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78B Buy
7,278,866
+189,727
+3% +$44.2M 4.55% 3
2025
Q4 		$1.47B Buy
7,089,139
+273,944
+4% +$54.2M 3.75% 6
2025
Q3 		$1.26B Buy
6,815,195
+260,764
+4% +$44.7M 3.56% 6
2025
Q2 		$1B Sell
6,554,431
-258,356
-4% -$39.7M 3.01% 7
2025
Q1 		$1.13B Buy
6,812,787
+452,544
+7% +$70.8M 3.56% 6
2024
Q4 		$920M Buy
6,360,243
+66,206
+1% +$10.3M 2.99% 8
2024
Q3 		$1.02B Buy
6,294,037
+269,651
+4% +$43M 3.2% 6
2024
Q2 		$881M Buy
6,024,386
+1,196,854
+25% +$178M 2.97% 6
2024
Q1 		$764M Buy
4,827,532
+841,168
+21% +$134M 2.78% 6
2023
Q4 		$625M Buy
3,986,364
+241,507
+6% +$37M 2.76% 5
2023
Q3 		$583M Buy
3,744,857
+382,035
+11% +$63M 2.75% 4
2023
Q2 		$557M Buy
3,362,822
+362,803
+12% +$58.6M 2.58% 6
2023
Q1 		$465M Buy
3,000,019
+65,324
+2% +$10.5M 2.37% 7
2022
Q4 		$518M Sell
2,934,695
-67,804
-2% -$11.7M 2.76% 3
2022
Q3 		$490M Buy
3,002,499
+728,785
+32% +$123M 2.83% 3
2022
Q2 		$404M Sell
2,273,714
-306,216
-12% -$54.6M 2.19% 6
2022
Q1 		$457M Buy
2,579,930
+24,261
+0.9% +$4.13M 2.21% 9
2021
Q4 		$437M Buy
2,555,669
+34,890
+1% +$5.71M 2.1% 12
2021
Q3 		$407M Buy
2,520,779
+123,148
+5% +$21M 2.01% 12
2021
Q2 		$395M Buy
2,397,631
+52,426
+2% +$8.68M 1.97% 13
2021
Q1 		$385M Buy
2,345,205
+11,452
+0.5% +$1.85M 2.11% 11
2020
Q4 		$367M Sell
2,333,753
-24,932
-1% -$3.68M 2.26% 8
2020
Q3 		$351M Buy
2,358,685
+84,414
+4% +$12.5M 2.5% 8
2020
Q2 		$320M Sell
2,274,271
-52,586
-2% -$7.66M 2.37% 8
2020
Q1 		$305M Sell
2,326,857
-318,681
-12% -$45.2M 2.54% 6
2019
Q4 		$386M Buy
2,645,538
+421,607
+19% +$57.2M 2.58% 6
2019
Q3 		$288M Buy
2,223,931
+65,566
+3% +$8.64M 2% 13
2019
Q2 		$301M Sell
2,158,365
-108,590
-5% -$15M 2.12% 8
2019
Q1 		$317M Sell
2,266,955
-179,454
-7% -$24M 2.28% 9
2018
Q4 		$316M Sell
2,446,409
-188,034
-7% -$26.2M 2.52% 7
2018
Q3 		$364M Sell
2,634,443
-993,046
-27% -$132M 2.47% 7
2018
Q2 		$440M Sell
3,627,489
-1,314,314
-27% -$164M 3.13% 5
2018
Q1 		$633M Buy
4,941,803
+622,584
+14% +$84.2M 3.87% 4
2017
Q4 		$603M Sell
4,319,219
-245,619
-5% -$34.2M 3.56% 4
2017
Q3 		$593M Sell
4,564,838
-485,071
-10% -$64.3M 3.47% 4
2017
Q2 		$668M Buy
5,049,909
+130,179
+3% +$16.6M 3.69% 4
2017
Q1 		$613M Sell
4,919,730
-335,604
-6% -$40.1M 3.46% 4
2016
Q4 		$605M Sell
5,255,334
-2,027,630
-28% -$234M 3.26% 5
2016
Q3 		$860M Sell
7,282,964
-2,458,456
-25% -$298M 4.06% 2
2016
Q2 		$1.18B Buy
9,741,420
+705,025
+8% +$80.1M 4.85% 1
2016
Q1 		$978M Sell
9,036,395
-934,036
-9% -$96.7M 3.65% 1
2015
Q4 		$1.02B Sell
9,970,431
-1,559,312
-14% -$157M 3.68% 3
2015
Q3 		$1.08B Sell
11,529,743
-1,377,456
-11% -$133M 3.74% 4
2015
Q2 		$1.26B Sell
12,907,199
-361,700
-3% -$36.2M 4.06% 2
2015
Q1 		$1.33B Buy
13,268,899
+1,571,158
+13% +$160M 3.98% 4
2014
Q4 		$1.22B Sell
11,697,741
-442,754
-4% -$46.7M 3.29% 8
2014
Q3 		$1.29B Sell
12,140,495
-2,156,738
-15% -$224M 3.43% 7
2014
Q2 		$1.5B Sell
14,297,233
-3,276,815
-19% -$331M 4.06% 4
2014
Q1 		$1.73B Sell
17,574,048
-2,201,576
-11% -$204M 4.5% 4
2013
Q4 		$1.81B Sell
19,775,624
-1,434,621
-7% -$132M 4.4% 4
2013
Q3 		$1.84B Sell
21,210,245
-1,961,446
-8% -$176M 4.85% 2
2013
Q2 		$1.99B Buy
+23,171,691
New +$1.97B 5.18% 1

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s JNJ Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Johnson & Johnson (JNJ) stake by 2.7% in Q1 2026, buying an estimated $44.2M and bringing the position to 7,278,866 shares worth $1.78B. The position accounts for 4.55% of the portfolio, ranked #3.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.99B in Q2 2013. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 7,278,866 shares of Johnson & Johnson worth $1.78B as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 189,727 Johnson & Johnson shares in Q1 2026, an estimated $44.2M.
  • Johnson & Johnson made up 4.55% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #3 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Johnson & Johnson position peaked at $1.99B in Q2 2013.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.